Effects of cell-permeable ceramides and tumor necrosis factor-α on insulin signaling and glucose uptake in 3T3-L1 adipocytes

Diabetes

Volumn 47, Issue 1, 1998, Pages 24-31

  Wang, Chuen Neu ^a   O'Brien, Lori ^a   Brindley, David N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CERAMIDE; DEOXYGLUCOSE; GLUCOSE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT SYSTEM; IMMUNOMODULATION; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031964986     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.1.24     Document Type: Article

References (62)

1. Kahn CR: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084, 1994
2. Himsworth H, Kerr RB: Insulin-sensitive and insulin-insensitive types of diabetes mellitus. Clin Sci 4:119-157, 1942
3. Kahn CR: Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 27:1893-1902, 1978
4. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor a: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
5. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM: Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. J Clin Invest 94:1543-1549, 1994
6. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor α inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854-4858, 1994
7. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A: Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055-26058, 1993
8. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271:665-668, 1995
9. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A: Tumor necrosis factor α-induced phosphorylation of insulin receptor substrate-1 (IRS-1). J Biol Chem 270:23780-23784, 1995
10. Guo D, Donner DB: Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J Biol Chem 271:615-618, 1996
11. Stephens JM, Lee J, Pilch PF: Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 272:971-976, 1997
12. Wiegmann K, Schütze S, Machleldt T, Witte D, Krönke M: Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005-1015, 1994
13. Hannun YA: The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269:3125-3128, 1994
14. Kolesnick R, Golde DW: The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325-328, 1994
15. 2-ceramide. J Biol Chem 270:12808-12813, 1995
16. Lozano J, Berra E, Municio MM, Diaz-Meco MT, Dominguez I, Sanz L, Moscat J: Protein kinase Cζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J Biol Chem 269:19200-19202, 1994
17. Gomez-Muñoz A, Martin A, O'Brien L, Brindley DN: Cell-permeable ceramides inhibit the stimulation of DNA synthesis and phospholipase D activity by phosphatidate and lysophosphatidate in rat fibroblasts. J Biol Chem 269:8937-8943, 1994
18. Venable MK, Blobe GC, Obeid LM: Identification of a defect in the phospholipase D/diacylglycerol pathway in cellular senescence. J Biol Chem 269:26040-26044, 1994
19. Gomez-Muñoz A, Waggoner DW, O'Brien L, Brindley DN: Interaction of ceramides, sphingesine and sphingosine-1-phosphate in regulating DNA synthesis and phospholipase D activity. J Biol Chem 270:26318-26325, 1995
20. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM: Tumor necrosis factor (TNF)-α inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271:13018-13022, 1996
21. Kanety H, Hemi R, Papa MZ, Karasik A: Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem 271:9895-9897, 1996
22. Begum N, Ragolia L: Effect of tumor necrosis factor-alpha on insulin action in cultured rat skeletal muscle cells. Endocrinology 137:2441-2440, 1996
23. Frost SC, Lane MD: Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem 260:2646-2652, 1985
24. Bielawska A, Linardic CM, Hannun YA: Modulation of cell growth and differentiation by ceramide. FEBS Lett 307:211-214, 1992
25. Kolesnick RN: Sphingomyelin and derivatives as cellular signals. Prog Lipid Res 30:1-38, 1991
26. Piper RC, Hess LJ, James DE: Differential sorting of two glucose transporters expressed in insulin-sensitive cells. Am J Physiol 260:C570-C580, 1991
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 103:265-275, 1951
28. Avruch J, Wallach DFH: Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells. Biochim Biophys Acta 233:334-347, 1971
29. White MF: The insulin receptor tyrosine kinase. In Peptide Hormone Action. Siddle K, Hutton JC, Eds. New York, Oxford University Press, 1990, p. 223-250
30. Folli F, Saad MJA, Backer JM, Kahn CR: Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J Biol Chem 267:22171-22177, 1992
31. Gomez-Muñoz A, Duffy PA, Martin A, O'Brien L, Byun H-S, Bittman R, Brindley DN: Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell permeable ceramides. Mol Pharmacol 47: 883-889, 1995
32. ras in insulin-stimulated glucose transport in 3T3-L1 adipocytes. J Biol Chem 269:21391-21394, 1994
33. Taha C, Mitsumoto Y, Liu Z, Skolnik EY, Klip A: The insulin-dependent biosynthesis of GLUT1 and GLUT3 glucose transporters in L6 muscle cells is mediated by distinct pathways. J Biol Chem 270:24678-24681, 1995
34. Szalkowski D, White-Carrington S, Berger J, Zhang B: Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 136:1474-1481, 1995
35. Cornelius P, Marlowe M, Lee MD, Pekala PH: The growth factor-like effects of tumor necrosis factor-alpha: stimulation of glucose transporter activity and induction of glucose transporter and immediate early gene expression in 3T3-L1 preadipocytes. J Biol Chem 265:20506-20516, 1990
36. Evans DA, Jacobs DO, Wilmore DW: Tumor necrosis factor enhances glucose uptake by peripheral tissues. Am J Physiol 257:R1182-R1189, 1989
37. S6K activation mediated by phosphatidylinositol-3-OH kinase. Nature 370:71-75, 1994
38. Yao B, Zhang Y, Delikat S, Mathias S, Basu S, Kolesnick R: Phosphorylation of Raf by ceramide-activated protein kinase. Nature 378:307-310, 1995
39. Turinsky J, Nagel GW, Elmemdorf JS, Damrau-Abney A, Smith TR: Sphingomyelinase stimulates 2-deoxyglucose uptake by skeletal muscle. Biochem J 313:215-222, 1996
40. McGowan KM, Police S, Winslow JB, Pekala PH: Tumor necrosis factor α regulation of glucose transporter (GLUT1) mRNA turnover. J Biol Chem 272:1331-1337, 1997
41. Marette A, Atgié C, Liu Z, Bukowiecki UJ, Klip A: Differential regulation of GLUT1 and GLUT4 glucose transporters in skeletal muscle of a new model of type II diabetes. Diabetes 42:1195-1201, 1993
42. Marsh BJ, Aim RA, McIntosh SR, James DE: Molecular regulation of GLUT4 targeting in 3T3-L1 adipocytes. J Cell Biol 130:1081-1091, 1995
43. Zorzano A, Wilkinson W, Kotliar N, Thoidis G, Wadzinkski BE, Ruoho AE, Pilch PF: Insulin-regulated glucose uptake in rat adipocytes is mediated by two transporter isoforms present in at least two vesicle populations. J Biol Chem 264:12358-12363, 1989
44. Cushman SW, Wardzala LJ: Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. J Biol Chem 255:4758-4762, 1980
45. Suzuki K, Kono T: Evidence that insulin causes the translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci USA 77:2542-2545, 1980
46. Clancy BM, Czech MP: Hexose transport stimulation and membrane redistribution of glucose transporters isoforms in response to cholera toxin, dibutyryl cyclic AMP, and insulin in 3T3-L1 adipocytes. J Biol Chem 265:12434-12443, 1990
47. Calderhead DM, Kitagawa K, Tanner LI, Holman GD, Lienhard GE: Insulin regulation of the two glucose transporters in 3T3-L1 adipocytes. J Biol Chem 265:13800-13808, 1990
48. Stephens JM, Pekala PH: Transcriptional repression of the C/EBP-α and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor α. J Biol Chem 267:13580-13584, 1992
49. Long SD, Pekala PH: Lipid mediators of insulin resistance: ceramide signaling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem J 319:179-184, 1996
50. Jhun BH, Rampal AL, Liu H, Lachaal M, Jung CY: Effects of insulin on steady state kinetics of GLUT4 subcellular distribution in rat adipocytes. J Biol Chem 267:17710-17715, 1992
51. Yang J, Holman GD: Comparison of GLUT4 and GLIT1 subcellular trafficking in basal and insulin-stimulated 3T3-L1 cells. J Biol Chem 268:4600-4603, 1993
52. Shibata H, Suzuki Y, Omata W, Tanaka S, Kojima I: Dissection of GLUT4 recycling pathway into exocytosis and endocytosis in rat adipocytes. J Biol Chem 270:11489-11495, 1995
53. Chen C-S, Rosenwald AG, Pagano RE: Ceramide as a modulator of endocytosis. J Biol Chem 270:13291-13297, 1995
54. Standaert ML, Bandyopadhyay G, Zhou X, Galloway L, Farese RV: Insulin stimulates phospholipase D-dependent phosphatidylcholine hydrolysis, Rho translocation, de novo phospholipid synthesis, and diacylglycerol/protein kinase C signaling in L6 myotubes. Endocrinology 137:3014-3020, 1996
55. Abousalham A, Liossis C, O'Brien L, Brindley DN: Cell-permeable ceramides prevent the activation of phospholipase D by ADP-ribosylation factor and RhoA. J Biol Chem 272:1069-1075, 1997
56. Jones MJ, Murray AW: Evidence that ceramide selectively inhibits protein kinase C-α translocation and modulates bradykinin activation of phospholipase D. J Biol Chem 70:5007-5013, 1995
57. Robinson LJ, James DE: Insulin-regulated sorting of glucose transporters in 3T3-L1 adipocytes. Am J Physiol 263:E383-E393, 1992
58. Kozma L, Baltensperger K, Klarlund J, Porras A, Santos E, Czech MP: The Ras signaling pathway mimics insulin action on glucose transporter translocation. Proc Natl Acad Sci USA 90:4460-4464, 1993
59. Ross SA, Scott HM, Morris NJ, Leung W-Y, Mao F, Lienhard GE, Keller SR: Characterization of the insulin-regulated membrane aminopeptidase in 3T3-L1 adipocytes. J Biol Chem 271:3328-3332, 1996
60. Simpson IA, Cushman SW: Hormonal regulation of mammalian glucose transport. Annu Rev Biochem 55:1059-1089, 1986
61. Baly DL, Horuk R: Dissociation of insulin-stimulated glucose transport from the translocation of glucose carriers in rat adipose cells. J Biol Chem 262:21-24, 1987
62. Armoni M, Harel C, Burvin R, Karnieli E: Modulation of the activity of glucose transporters (GLUT) in the aged/obese rat adipocyte: suppressed function, but enhanced intrinsic activity of GLUT. Endocrinology 136:3292-3298, 1995